FDA Grants IND For Advanced GT20029 PROTAC Drug: Update (7/13/21)
This is the much anticipated Androgen Degrader from Kintor!
Great news coming out from Kintor. Their on absolute fire whilst most others are taking their own sweet time.
Kintor Announces New Advanced Androgen Receptor Drug GT20029 - Follicle Thought
China Trial Enrolls 180 Patients To Complete Enrollment: Update (8/22/23) On August 22, 2023, Kintor Pharmaceutical announced the completion of patient enrollment in a phase 2 trial in China for GT20029. This means all of the patients needed to complete the study have been enrolled, and will...
www.folliclethought.com
Credit to the Admin of Follicle Thought